Semax Laboratory Grade — Poland
Research Use Only: All compounds supplied by Aarise Healthcare are strictly for laboratory research and scientific investigation. Not intended for human consumption, therapeutic use, or clinical application. All purchases must comply with applicable local laws and regulations.
Aarise Healthcare exports Semax (CAS: 80714-61-0) to research institutions in Poland. Our WHO-GMP certified facility in India supplies 98%+ purity Semax for neuroprotective and cognitive enhancement research.
Semax Export Specifications for Poland
| Compound | Semax |
| CAS Number | 80714-61-0 |
| Purity | 98%+ (HPLC verified) |
| Form | Lyophilised powder |
| Regulatory Reference | URPL |
| Shipping | DHL/FedEx temperature-controlled |
| Transit to Poland | 5-10 business days |
| Documentation | CoA, HPLC, MS, export docs |
Research Applications of Semax
Semax is used in neuroprotective and cognitive enhancement research. Research institutions in Poland source this compound for preclinical studies under applicable URPL research regulations.
Why Poland Researchers Source Semax from India
- WHO-GMP certified Indian manufacturer — internationally recognised compliance
- Competitive pricing for bulk research quantities
- Full export documentation package for URPL compliance
- Temperature-controlled DHL/FedEx shipping to Poland
- Dedicated international research supply team
- 98%+ purity guaranteed with independent third-party CoA
Related Peptides in Poland
Semaglutide in Poland | Tirzepatide in Poland | Retatrutide in Poland | Liraglutide in Poland
Semax — Other Countries
Semax in USA | Semax in UK | Semax in Germany | Semax in Australia
Source from India — Key Manufacturing Cities
Semax in Mumbai, India | Semax in Delhi, India | Semax in Hyderabad, India | Semax in Bangalore, India
Request Semax for your Poland research facility: Send your institution details and quantity requirements. We respond within 24 hours with FOB pricing and export documentation.
